A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Nov 18, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q3 FY2026, filed Nov 4, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the ALL SEC filings page.
The Allstate Corporation (ALL) reported $70.2B in revenue over the twelve months to Sep 30, 2026, up 5.1% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Allstate’s 2025 results show a business converting earnings into cash while stronger equity and lower debt reduced balance-sheet pressure.
Operating cash flow reached$10.1B against net income of$10.3B in FY2025; the near-match indicates reported earnings largely became cash rather than remaining tied up elsewhere. Yet operating cash flow was98.3% of net income, down from191.4% in FY2024, showing that the prior year’s unusually high conversion did not persist.
Equity rose
Capital expenditures were just
Financial Health Signals
We do not publish a peer-relative financial health score for The Allstate Corporation, because the score only covers companies whose filings and listing give us what it needs to compare them with their peers. The signals and metrics below are current.
The Allstate Corporation passes 5 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 3 of 4 profitability signals pass, all 2 leverage/liquidity signals pass, the one computable operating efficiency signal (asset turnover improving) does not pass.
Key Financial Metrics
Earnings & Revenue
The Allstate Corporation generated $17.3B in revenue in Q3 2026. This represents an increase of 0.5% from the same quarter a year earlier. Against the prior quarter it is down 6.7%.
The Allstate Corporation reported $2.1B in net income in Q3 2026. This represents a decrease of 44.5% from the same quarter a year earlier. Against the prior quarter it is down 36.4%.
The Allstate Corporation earned $8.03 per diluted share (EPS) in Q3 2026. This represents a decrease of 42.4% from the same quarter a year earlier. Against the prior quarter it is down 35.8%.
Not reported for Q3 2026.
Cash & Balance Sheet
The Allstate Corporation generated $3.7B in free cash flow in Q3 2026, representing cash available after capex. This represents an increase of 15.0% from the same quarter a year earlier. Against the prior quarter it is up 43.6%.
The Allstate Corporation held $549.0M in cash against $7.5B in long-term debt as of Q3 2026.
The Allstate Corporation paid $1.08 per share in dividends in Q3 2026. This represents an increase of 8.0% from the same quarter a year earlier. It is unchanged from the prior quarter.
Margins & Returns
The Allstate Corporation's net profit margin was 12.0% in Q3 2026, showing the share of revenue converted to profit. This is down 9.7 percentage points from the same quarter a year earlier. Against the prior quarter it is down 5.6 percentage points.
The Allstate Corporation's quarterly ROE was 6.4% in Q3 2026: one quarter's net income over shareholder equity, not annualized. This is down 7.2 percentage points from the same quarter a year earlier. Against the prior quarter it is down 3.3 percentage points.
Not reported for Q3 2026.
Not reported for Q3 2026.
Capital Allocation
The Allstate Corporation spent $1.2B on share buybacks in Q3 2026, returning capital to shareholders by reducing shares outstanding. This represents an increase of 244.2% from the same quarter a year earlier. Against the prior quarter it is up 17.9%.
The Allstate Corporation invested $62.0M in capex in Q3 2026, funding long-term assets and infrastructure. This represents an increase of 29.2% from the same quarter a year earlier. Against the prior quarter it is up 44.2%.
Not reported for Q3 2026.
ALL Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Revenue | $17.3B+0.5% | $18.6B+11.8% | $16.9B+3.0% | $17.3B+5.1% | $17.3B+3.8% | $16.6B+5.8% | $16.5B+7.8% | $16.5B+11.3% |
| Interest Expense | $97.0M-4.0% | $96.0M-4.0% | $98.0M-2.0% | N/A | $101.0M-2.9% | $100.0M+2.0% | $100.0M+3.1% | N/A |
| Income Tax | $537.0M-50.0% | $871.0M+44.2% | $650.0M+428.5% | N/A | $1.1B+323.2% | $604.0M+627.7% | $123.0M-53.8% | N/A |
| Net Income | $2.1B-44.5% | $3.3B+55.1% | $2.5B+312.9% | $3.8B+100.3% | $3.7B+214.8% | $2.1B+537.2% | $595.0M-51.1% | $1.9B+30.1% |
| EPS (Basic) | $8.15-42.3% | $12.66+61.1% | $9.36+339.4% | $14.55+103.2% | $14.13+221.9% | $7.86+589.5% | $2.13-52.8% | $7.16+28.5% |
| EPS (Diluted) | $8.03-42.4% | $12.51+61.2% | $9.25+338.4% | $14.37+103.3% | $13.95+222.2% | $7.76+586.7% | $2.11-52.7% | $7.07+28.1% |
| Diluted Shares (Avg) | 255M-4.2% | 259M-3.3% | 263M-2.3% | N/A | 266M-0.6% | 268M+0.3% | 269M+0.9% | N/A |
Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA.
ALL Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'25Filing | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $127.8B+6.2% | $124.8B+7.6% | $124.0B+7.7% | $119.8B+7.3% | $120.4B+5.9% | $115.9B+6.9% | $115.2B+9.4% | $111.6B+8.0% |
| Cash & Equivalents | $549.0M-41.0% | $840.0M-15.6% | $697.0M-17.0% | $678.0M-3.7% | $931.0M+14.1% | $995.0M+66.1% | $840.0M-1.2% | $704.0M-2.5% |
| Short-Term Investments | $5.8B-33.9% | $4.9B-49.5% | $4.7B-28.1% | $4.9B+7.7% | $8.7B+25.0% | $9.6B+82.3% | $6.5B+51.5% | $4.5B-11.8% |
| Goodwill | $3.1B0.0% | $3.1B0.0% | $3.1B+0.1% | $3.1B-3.9% | $3.1B-2.7% | $3.1B-11.0% | $3.1B-11.1% | $3.2B-7.3% |
| Total Liabilities | $95.6B+2.8% | $91.1B-0.9% | $92.4B-0.8% | $89.2B-1.2% | $92.9B0.0% | $91.9B+2.3% | $93.1B+7.3% | $90.3B+5.3% |
| Long-Term Debt | $7.5B-7.4% | $7.5B-7.4% | $7.5B-7.4% | $7.5B-7.4% | $8.1B+0.1% | $8.1B+0.1% | $8.1B+1.9% | $8.1B+1.8% |
| Total Equity | $32.3B+17.5% | $33.7B+40.3% | $31.6B+43.3% | $30.6B+42.8% | $27.5B+31.7% | $24.0B+29.2% | $22.1B+18.3% | $21.4B+20.7% |
| Retained Earnings | $69.3B+17.7% | $67.5B+21.8% | $64.5B+20.4% | $62.4B+17.1% | $58.9B+14.0% | $55.4B+9.2% | $53.6B+5.8% | $53.3B+7.2% |
Not reported in any period shown, so not listed: Current Assets, Inventory, Accounts Receivable, Long-Term Investments, Current Liabilities, Non-Current Liabilities.
ALL Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $3.8B+15.2% | $2.6B+40.6% | $3.6B+81.4% | $3.0B+75.3% | $3.3B+2.6% | $1.9B-20.6% | $2.0B+17.9% | $1.7B+39.2% |
| Depreciation & Amortization | $81.0M-29.6% | $86.0M-32.3% | $101.0M-23.5% | $108.0M-28.5% | $115.0M-17.9% | $127.0M-3.8% | $132.0M0.0% | $151.0M-8.5% |
| Capital Expenditures | $62.0M+29.2% | $43.0M | $40.0M-56.5% | $89.0M+78.0% | $48.0M-23.8% | N/A | $92.0M+124.4% | $50.0M-29.6% |
| Free Cash Flow | $3.7B+15.0% | $2.6B | $3.5B+88.1% | $2.9B+75.2% | $3.2B+3.1% | N/A | $1.9B+15.2% | $1.7B+43.4% |
| Investing Cash Flow | -$2.6Bn/m | -$1.2Bn/m | -$2.6Bn/m | -$1.9Bn/m | -$2.8Bn/m | -$1.2Bn/m | -$1.3Bn/m | -$1.7Bn/m |
| Financing Cash Flow | -$1.5Bn/m | -$1.3Bn/m | -$916.0Mn/m | -$1.3Bn/m | -$634.0Mn/m | -$620.0Mn/m | -$334.0Mn/m | -$260.0Mn/m |
| Dividends Paid | $275.0M+4.2% | $280.0M+5.7% | $261.0M+7.0% | $263.0M+8.2% | $264.0M+8.6% | $265.0M+9.1% | $244.0M+4.7% | $243.0M+4.3% |
| Share Buybacks | $1.2B+244.2% | $1.1B+209.1% | $614.0M+520.2% | $434.0M+21600.0% | $360.0Mn/m | $340.0Mn/m | $99.0Mn/m | $2.0Mn/m |
Not reported in any period shown, so not listed: Stock-Based Compensation.
ALL Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Net Margin | 12.0%-9.7pp | 17.6%+4.9pp | 14.5%+10.9pp | 21.9%+10.4pp | 21.7%+14.5pp | 12.7%+10.6pp | 3.6%-4.4pp | 11.5%+1.7pp |
| Return on Equity | 6.4%-7.2pp | 9.7%+0.9pp | 7.8%+5.1pp | 12.4%+3.6pp | 13.6%+7.9pp | 8.8%+7.0pp | 2.7%-3.8pp | 8.9%+0.6pp |
| Return on Assets | 1.6%-1.5pp | 2.6%+0.8pp | 2.0%+1.5pp | 3.2%+1.5pp | 3.1%+2.1pp | 1.8%+1.5pp | 0.5%-0.6pp | 1.7%+0.3pp |
| Debt-to-Equity | 0.23-0.1x | 0.22-0.1x | 0.24-0.1x | 0.24-0.1x | 0.29-0.1x | 0.34-0.1x | 0.37-0.1x | 0.38-0.1x |
| Liabilities-to-Equity | 2.96-0.4x | 2.70-1.1x | 2.92-1.3x | 2.91-1.3x | 3.38-1.1x | 3.83-1.0x | 4.22-0.4x | 4.21-0.6x |
| Asset Turnover | 0.140.0x | 0.150.0x | 0.140.0x | 0.140.0x | 0.140.0x | 0.140.0x | 0.140.0x | 0.150.0x |
| FCF Margin | 21.4%+2.7pp | 13.9% | 20.8%+9.4pp | 16.7%+6.7pp | 18.8%-0.1pp | N/A | 11.4%+0.7pp | 10.0%+2.3pp |
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Current Ratio.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| The Allstate Corporation ALL | FY2025 | $67.7B | $10.3B | 15.2% | $66.0B | — |
| The Travelers Companies, Inc. TRV | FY2025 | $48.8B | $6.3B | 12.9% | $80.3B | 57/100 |
| Chubb Limited CB | FY2025 | $59.4B | $10.3B | 17.4% | $141.8B | 72/100 |
| Progressive Corporation PGR | FY2025 | $87.7B | $11.3B | 12.9% | $132.4B | 59/100 |
| Cincinnati Financial Corp CINF | FY2025 | $12.6B | $2.4B | 18.9% | $29.0B | 61/100 |
| W.R. Berkley Corporation WRB | FY2025 | $14.7B | $1.8B | 12.1% | $28.6B | 64/100 |
Where The Allstate Corporation Ranks
Frequently Asked Questions
The Allstate Corporation (ALL) reported $67.7B in total revenue for fiscal year 2025. This represents a 5.6% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
The Allstate Corporation (ALL) revenue grew by 5.6% year-over-year, from $64.1B to $67.7B in fiscal year 2025.
Yes, The Allstate Corporation (ALL) reported a net income of $11.6B over the trailing 12 months to September 30, 2026. In fiscal year 2025 it reported a net income of $10.3B, with a net profit margin of 15.2%.
As of fiscal year 2025, The Allstate Corporation (ALL) had $678.0M in cash and equivalents against $7.5B in long-term debt.
The Allstate Corporation (ALL) had a net profit margin of 15.2% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
Yes, The Allstate Corporation (ALL) paid $4.00 per share in dividends during fiscal year 2025.
The Allstate Corporation (ALL) has a return on equity of 33.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
The Allstate Corporation (ALL) generated $9.9B in free cash flow during fiscal year 2025. This represents a 13.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
The Allstate Corporation (ALL) generated $10.1B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
The Allstate Corporation (ALL) had $119.8B in total assets as of fiscal year 2025, including both current and long-term assets.
The Allstate Corporation (ALL) invested $228.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
The Allstate Corporation (ALL) had a debt-to-equity ratio of 0.24 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.
The Allstate Corporation (ALL) had a liabilities-to-equity ratio of 2.91 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.
The Allstate Corporation (ALL) had a return on assets of 8.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
The Allstate Corporation (ALL) trades at 5.7x earnings, its market capitalization divided by $11.6B net income, trailing 12 months to September 30, 2026. The market capitalization is $66.0B as of Nov 18, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
The Allstate Corporation (ALL) trades at 0.9x sales, its market capitalization divided by $70.2B revenue, trailing 12 months to September 30, 2026. The market capitalization is $66.0B as of Nov 18, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
The Allstate Corporation (ALL) has a Piotroski F-Score of 5 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.